Study Data from Stanford University Update Knowledge of Serous Carcinoma (Nuclear Beta-catenin Expression In the Context of Abnormal P53 Expression Indicates a Nonserous Histotype In Endometrial Carcinoma).

Keywords: Stanford; State:California; United States; North and Central America; Armadillo Domain Proteins; Cancer; Carcinomas; Catenins; Endometrial Cancer; Genetics; Gynecology; Health and Medicine; Oncology; Proteins; Serous Carcinoma; Transcription Factors; Women's Health; beta Catenin; p53 Gene EN Stanford State:California United States North and Central America Armadillo Domain Proteins Cancer Carcinomas Catenins Endometrial Cancer Genetics Gynecology Health and Medicine Oncology Proteins Serous Carcinoma Transcription Factors Women's Health beta Catenin p53 Gene 1217 1217 1 09/19/23 20230922 NES 230922 2023 SEP 19 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Research findings on Oncology - Serous Carcinoma are discussed in a new report. Eighty ECs were identified in the "p53-abnormal" category; 27 (33.75%) were uterine serous carcinomas, and 53 were of nonserous histotype: 28 uterine carcinosarcomas (35%), 16 endometrioid carcinomas (20%), 2 clear cell carcinomas (2.5%), and 7 high-grade EC with ambiguous morphology (8.75%). [Extracted from the article]